Albert David Stock Screener | Share Price & Fundamental Analysis
ALBERTDAVD
Pharmaceuticals
Share Price NSE
₹690.80
▲
15.20 (2.25%)
Share Price BSE
₹690.15
▲
30.15 (4.57%)
Track Albert David share price live with TickJournal's free stock screener.
Analyze Albert David share price history trends and compare 52-week high low
levels.
Calculate ALBERTDAVD stock fair value using fundamental analysis and view live share price charts.
Determine Albert David share intrinsic value and compare it with current ALBERTDAVD share price.
Record your Albert David trades in TickJournal's free trading journal and track your portfolio performance.
Albert David Market Cap
₹370.25 Cr.
EPS (TTM)
₹30.14
Dividend Yield
0.74%
Debt to Equity
0.02
ALBERTDAVD 52 Week High
₹946.55
Albert David 52 Week Low
₹648.75
Operating Margin
-2.00%
Profit Margin
2.86%
ALBERTDAVD Revenue (TTM)
₹350.00
EBITDA
₹25.00
Net Income
₹10.00
Total Assets
₹511.00
Total Equity
₹393.00
Albert David Share Price History - Stock Screener Chart
Screen ALBERTDAVD historical share price movements with interactive charts. Analyze price trends and patterns.
Albert David Company Profile - Fundamental Screener
Screen Albert David company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ALBERTDAVD shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE155C01010
Albert David Balance Sheet Screener
Screen ALBERTDAVD balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 511 | 498 | 423 | 401 | 341 | 320 | 295 | 290 | 285 | 224 |
| Current Assets | 354 | 372 | 304 | 253 | 223 | 201 | 186 | 172 | 164 | 152 |
| Fixed Assets | 99 | 83 | 80 | 88 | 84 | 91 | 77 | 83 | 87 | 44 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 15 | 16 | 13 | 14 | 16 | 16 | 16 | 15 | 14 | 12 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 393 | 383 | 312 | 280 | 244 | 223 | 210 | 186 | 183 | 137 |
| Share Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves & Surplus | 387 | 377 | 306 | 274 | 239 | 217 | 205 | 180 | 177 | 131 |
Albert David Income Statement Screener - Profit & Revenue Analysis
Screen Albert David income statement and profit fundamentals.
Analyze ALBERTDAVD quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Albert David share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 350 | 375 | 420 | 357 | 329 | 265 | 328 | 324 | 296 | 303 | 325 | 324 |
| Expenses | 325 | 343 | 316 | 297 | 273 | 228 | 291 | 287 | 266 | 268 | 292 | 285 |
| EBITDA | 25 | 33 | 104 | 60 | 57 | 36 | 37 | 36 | 31 | 36 | 33 | 38 |
| Operating Profit % | -2.00% | 1.00% | 13.00% | 13.00% | 13.00% | 8.00% | 9.00% | 9.00% | 8.00% | 9.00% | 10.00% | 11.00% |
| Depreciation | 9 | 7 | 7 | 9 | 9 | 8 | 8 | 7 | 8 | 8 | 9 | 15 |
| Interest | 2 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 |
| Profit Before Tax | 14 | 25 | 97 | 51 | 47 | 27 | 29 | 29 | 22 | 27 | 63 | 20 |
| Tax | 5 | 8 | 22 | 15 | 12 | 5 | 10 | 11 | 8 | 10 | 15 | 7 |
| Net Profit | 10 | 17 | 75 | 36 | 35 | 22 | 19 | 18 | 14 | 17 | 48 | 14 |
| EPS | 16.80 | 30.14 | 132.15 | 63.39 | 61.78 | 38.80 | 33.59 | 46.68 | 17.24 | 27.96 | 84.10 | 24.01 |
Albert David Cash Flow Screener - Liquidity Fundamentals
Screen ALBERTDAVD cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -28 | 46 | 11 | 40 | 37 | 30 | 32 | 30 | 20 | 68 |
| Investing Activities | 23 | -33 | -5 | -40 | -37 | -20 | -19 | -11 | -36 | -38 |
| Financing Activities | 0 | -8 | -6 | -2 | -2 | -10 | -17 | -5 | 7 | -18 |
| Net Cash Flow | -5 | 4 | -1 | -1 | -2 | 0 | -4 | 15 | -10 | 12 |
Albert David Shareholding Pattern Screener
See Albert David shareholding pattern with promoter, FII, and DII holdings.
Check Albert David promoter holding and ownership changes for ALBERTDAVD on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 62.24% | 62.24% | 62.24% | 62.24% | 62.13% | 62.13% | 62.13% | 62.13% |
| FII Holding | 1.01% | 0.84% | 0.60% | 0.60% | 0.98% | 0.80% | 0.88% | 0.86% |
| DII Holding | 1.65% | 1.66% | 1.66% | 1.66% | 1.67% | 1.67% | 1.64% | 1.64% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 27.43% | 27.81% | 27.72% | 27.36% | 26.71% | 27.27% | 27.63% | 27.92% |
| Other Holding | 7.68% | 7.45% | 7.78% | 8.14% | 8.51% | 8.13% | 7.72% | 7.45% |
| Shareholder Count | 15,304 | 15,070 | 14,666 | 13,967 | 11,266 | 12,349 | 13,590 | 14,830 |
Albert David Share Dividend Screener - Share Yield Analysis
Check Albert David dividend history with payout and yield data.
View Albert David dividend details including ex-dates and amounts for ALBERTDAVD stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹5.00 | 0.74% |
| 2024-March | ₹11.50 | 1.42% |
| 2023-March | ₹9.00 | 0.84% |
| 2022-March | ₹9.00 | 1.73% |
| 2021-March | ₹6.00 | 1.13% |
| 2020-March | ₹7.00 | 1.86% |
| 2019-March | ₹6.00 | 1.88% |
| 2018-March | ₹5.50 | 1.41% |
| 2017-March | ₹5.50 | 1.50% |
Albert David Stock Index Membership
See which indices include Albert David stock.
Check ALBERTDAVD index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Albert David Market Events Screener - Corporate Actions
Get Albert David corporate actions including splits, bonuses, and buybacks.
Check Albert David stock events that may affect ALBERTDAVD share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 6.00 /share | 18.32% | ||
| 2026-02-11 | 2026-02-11 | Quarterly Result Announcement | NA | 3.22% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 2.06% |
| 2025-08-02 | 2025-08-02 | Annual General Meeting | NA | -2.40% |
| 2025-08-02 | 2025-08-02 | Quarterly Result Announcement | NA | -3.76% |
| 2025-07-25 | 2025-07-25 | Dividend | ₹ 5.00 /share | 1.41% |
| 2025-05-13 | 2025-05-13 | Quarterly Result Announcement | NA | 6.87% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -5.53% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -2.51% |
| 2024-08-09 | 2024-08-09 | Annual General Meeting | NA | 12.46% |
| 2024-08-02 | 2024-08-02 | Dividend | ₹ 11.50 /share | 15.99% |
| 2023-08-03 | 2023-08-03 | Dividend | ₹ 9.00 /share | 27.61% |
| 2022-08-01 | 2022-08-02 | Dividend | ₹ 9.00 /share | 0.89% |
Albert David Competitors Screener - Peer Comparison
Screen ALBERTDAVD competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 433,656 | 39.41 | 54,729 | 9.71% | 10,980 | 67.71 |
| Divis Laboratories | 168,042 | 67.76 | 9,712 | 18.67% | 2,191 | 52.59 |
| Torrent Pharmaceuticals | 148,026 | 64.17 | 11,539 | 6.99% | 1,911 | 64.43 |
| Dr Reddys Laboratories | 107,417 | 19.71 | 33,741 | 16.73% | 5,725 | 53.09 |
| Cipla | 107,030 | 23.55 | 28,410 | 7.12% | 5,291 | 42.99 |
| Lupin | 105,205 | 22.95 | 22,910 | 13.74% | 3,306 | 60.69 |
| Zydus Life Science | 91,452 | 18.28 | 23,511 | 18.55% | 4,615 | 50.44 |
| Mankind Pharma | 89,302 | 50.06 | 12,744 | 20.90% | 2,007 | 52.07 |
| Aurobindo Pharma | 72,443 | 20.53 | 32,346 | 9.43% | 3,484 | 61.78 |
| Alkem Laboratories | 65,282 | 27.34 | 13,458 | 3.70% | 2,216 | 43.73 |
Albert David Company Announcements - News Screener
Screen ALBERTDAVD latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-11 | Unaudited Financial Results For The Third Quarter And Nine Months Ended 31St December 2025 | View |
| 2026-02-11 | Board Meeting Outcome for Outcome Of Board Meeting Held On 11Th February 2026 | View |
| 2026-02-02 | Board Meeting Intimation for To Consider And Approve Unaudited Financial Results For The Third Quarter And Nine Months Ended 31St December 2025. | View |
| 2026-01-17 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2026-01-05 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-12-22 | Closure of Trading Window | View |
| 2025-12-22 | Closure of Trading Window | View |
| 2025-12-19 | Announcement under Regulation 30 (LODR)-Resignation of Director | View |
| 2025-12-19 | Announcement under Regulation 30 (LODR)-Resignation of Managing Director | View |
| 2025-12-19 | Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO) | View |
| 2025-12-18 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-12-18 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-12-18 | Board Meeting Outcome for Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Resignation Of Managing Director CEO & Director | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Unaudited Financial Results For Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of Board Meeting Dated 12.11.2025 | View |
| 2025-11-05 | Board Meeting Intimation for To Consider And Approve Unaudited Financial Results For Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-01 | Intimation Of Board Meeting To Approve Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended 30Th September 2025. | View |
| 2025-10-08 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |